5,932 Shares in SPDR S&P Biotech ETF $XBI Purchased by Integrity Alliance LLC.

Integrity Alliance LLC. acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 5,932 shares of the exchange traded fund’s stock, valued at approximately $723,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of XBI. AQR Capital Management LLC increased its position in SPDR S&P Biotech ETF by 77.1% during the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock worth $404,000 after purchasing an additional 2,167 shares during the last quarter. Marshall Wace LLP boosted its stake in SPDR S&P Biotech ETF by 102.3% during the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after buying an additional 179,029 shares during the period. The Manufacturers Life Insurance Company purchased a new position in SPDR S&P Biotech ETF during the second quarter worth about $260,000. Ameriprise Financial Inc. boosted its stake in SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after buying an additional 481,408 shares during the period. Finally, EP Wealth Advisors LLC boosted its stake in SPDR S&P Biotech ETF by 3.7% during the second quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock worth $446,000 after buying an additional 193 shares during the period.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $136.69 on Friday. SPDR S&P Biotech ETF has a one year low of $78.06 and a one year high of $139.19. The firm has a 50 day simple moving average of $130.99 and a 200-day simple moving average of $125.94. The firm has a market cap of $8.72 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.